Home
Search
Study Topics
Glossary
|
|
|
|
|
Sponsors and Collaborators: |
Bispebjerg Hospital Imperial College London Anti Doping Danmark GlaxoSmithKline The Research Foundation of Bispebjerg Hospital Ragnhild Ibsens Legat for Medicinsk Forskning |
---|---|
Information provided by: | Bispebjerg Hospital |
ClinicalTrials.gov Identifier: | NCT00262587 |
International studies have shown that elite athletes have a high prevalence of respiratory symptoms and asthma as compared to normal subjects. It is unclear whether the increased prevalence of asthma in elite athletes reflects "traditional asthma" or whether it is a special form of "sports asthma". The treatment of elite athletes with asthma seems to vary widely, and only a few studies have focused on the treatment of elite athletes with asthma. Further knowledge of the pathogenesis of sports asthma would lead to a greater understanding and better treatment of the condition. This study will investigate the type of airway inflammation in elite athletes and examine the effect of treatment with inhaled steroids in combination with long-acting beta-agonists versus placebo in the same group.
Condition | Intervention | Phase |
---|---|---|
Asthma |
Drug: Seretide |
Phase IV |
Study Type: | Interventional |
Study Design: | Treatment, Randomized, Double Blind (Subject, Investigator), Placebo Control, Parallel Assignment |
Official Title: | Elite Sport and Development of Asthma |
Ages Eligible for Study: | 18 Years to 35 Years |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | Yes |
Inclusion Criteria:
Exclusion Criteria:
Contact: Thomas Lund, MD | (+45) 35316820 | tclund21@hotmail.com |
Contact: Vibeke Backer, MD | (+45) 35313569 |
Denmark | |
Respiratory and Allergy Research Unit, Department of Respiratory Medicine, Bispebjerg Hospital | Recruiting |
Copenhagen, Denmark, DK-2400 NV | |
Contact: Thomas Lund, MD (+45) 35316820 tclund21@hotmail.com | |
Principal Investigator: Thomas Lund, MD |
Principal Investigator: | Thomas Lund, MD | Respiratory and Allergy Research Unit, Department of Respiratory Medicine |
Study ID Numbers: | 2005-061, (KF) 01 262958 |
Study First Received: | December 6, 2005 |
Last Updated: | November 2, 2007 |
ClinicalTrials.gov Identifier: | NCT00262587 History of Changes |
Health Authority: | Denmark: Danish Medicines Agency |
Sport Asthma Treatment Airway inflammation |
Hypersensitivity Lung Diseases, Obstructive Respiratory Tract Diseases Bronchial Diseases Lung Diseases |
Hypersensitivity, Immediate Asthma Respiratory Hypersensitivity Inflammation |
Hypersensitivity Lung Diseases, Obstructive Immune System Diseases Respiratory Tract Diseases Bronchial Diseases |
Lung Diseases Hypersensitivity, Immediate Asthma Respiratory Hypersensitivity |